Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 414

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 414
---
 of shares of New Semnur Common Stock if determined by the New Semnur Board to be in the best interests of New Semnur after the consummation of the Business Combination without incurring the risk, delay and potential expense incident to obtaining stockholder approval to increase the authorized share capital. In connection with the Business Combination, an aggregate of 277,087,600 shares of New Semnur Common Stock are needed to complete the Business Combination, comprised of:

| • |     | 200,000,000 shares of New Semnur Common Stock to be issued to Scilex as Merger Consideration; |

| • |     | up to a maximum of 600,000 shares of New Semnur Common Stock to be issued to Scilex (and its affiliate, Scilex Bio) as the sole holder of Semnur Series A Preferred Stock as Preferred Consideration; |

| • |     | up to a maximum of 6,000,000 shares of New Semnur Series A Preferred stock to be issued to Scilex as the sole holder of Semnur Series A Preferred Stock as Preferred Consideration; |

| • |     | assuming approval of the Option Exchange Proposal, up to a maximum of 50,000,000 shares of New Semnur Common Stock that will be issuable upon exercise of options to purchase shares of New Semnur Common Stock; |

| • |     | 2,799,715 shares of New Semnur Common Stock to be issued in exchange for the same number of Denali Ordinary Shares; |

| • |     | 524,622 shares of New Semnur Common Stock to be issued upon the automatic separation of Units into their component parts; |

| • |     | 323,161 shares of New Semnur Common Stock, to be issued upon conversion (if converted) of the Denali Convertible Promissory Notes (taking into account accrued interest through September 30, 2025), of which Scilex will hold 18,000 shares; |

| • |     | 86,625 shares of New Semnur Common Stock expected to be issued to the Denali Underwriters pursuant to a deferred discount agreement to be entered into; |

| • |     | 8,000,000 shares of New Semnur Common Stock to be issued immediately following the Closing pursuant to the Consulting Services Agreements; and |

| • |     | 8,760,000 shares of New